< Back to companies
GeneproDX

GeneproDX

Providencia, Chile

Geneprodx us a clinical laboratory devoted to the molecular diagnostic of thyroid cancer. Geneprodx developed ThyroidPrint®, a test the will prevent 88% of unnecessary surgery practiced on patients with an undetermined diagnostic. ThyroidPrint® is the only genetic test for thyroid cancer that has been validated in two independent clinical trials: USA and Chile.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2014
Website
www.geneprodx.com/
Only accessible to MedStartr community members. Join now

What do you think of GeneproDX?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now